Metoprolol Succinate Tablet, Extended Release
Product Images NDC 69097-409

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 69097-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00df8655 C4ff 481f Bd4f E43b69b3a059 01)

Chemical structure of metoprolol succinate showing the molecular arrangement of atoms including hydroxyl, ether, amine, and carboxyl groups in the compound.*

FDA Label Image

Merit Hf (00df8655 C4ff 481f Bd4f E43b69b3a059 02)

A results chart for subgroups in the MERIT-HF study showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. It compares outcomes for metoprolol succinate extended-release tablets versus placebo across various demographics and clinical subgroups.*

FDA Label Image

50mg (00df8655 C4ff 481f Bd4f E43b69b3a059 03)

Label for Metoprolol Succinate extended-release tablets, USP, 50 mg strength. The label shows 100 tablets in the package. It includes storage instructions and cautions, listing Cipla USA Inc. as the labeler and Cipla Ltd. in India as the manufacturer. The label features NDC 69097-407-07 and a barcode.*

FDA Label Image

100mg (00df8655 C4ff 481f Bd4f E43b69b3a059 04)

Label for Metoprolol Succinate extended-release tablets, USP, 100 mg strength, in a package of 100 tablets. Manufactured by Cipla Ltd., India, for Cipla USA Inc. The label includes storage instructions, a caution to verify the product dispensed, and various manufacturing details and barcodes. The label uses dark pink, red, blue, and black colors.*

FDA Label Image

200mg (00df8655 C4ff 481f Bd4f E43b69b3a059 05)

Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, manufactured by Cipla Ltd. and labeled by Cipla USA Inc. The packaging indicates 100 tablets per bottle with storage instructions and a caution to verify product dispensed. The label includes dosage form, strength, and NDC 69097-409-07.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.